Child dies after vaccination, doctors face action |  |
- Child dies after vaccination, doctors face action
- Agilent Technologies and A*STAR launch all-in-one drug screening platform
- Forest fungus factory
- BUSM/BMC researchers awarded $3.5 million grant from the NIDA
- Social media study: Conservatives were top tweeters in 2010 elections
| Child dies after vaccination, doctors face action Posted: 22 Jul 2011 01:00 PM PDT ( From http://www.rxpgnews.com ) Lucknow, July 22 - Action has been recommended against a deputy chief medical officer and another doctor after an infant died and two others took ill following administration of measles vaccine in Uttar Pradesh, an official said Friday. While nine-month-old Shivansh died Thursday at the Chhatrapati Sahuji Maharaj Medical University - here, two other children - Lallu and Sadhu - are being treated for post-vaccination complication. They were Wednesday administered measles vaccine under routine immunisation campaign in Awadhpur village in Barabanki, 30 km from Lucknow. On Thursday, they were admitted to the CSMMU. 'It appears prescribed norms were not followed while administering the vaccine,' Barabanki Chief Medical Officer A.K. Chaudhary told reporters. 'The measles vaccine should have been utilised within four hours after dissolution but it was kept open for more than eight hours,' he added. 'We have suspended an ANM - involved in the vaccination. Action has been recommended against doctor Arvind Yadav and Deputy Chief Medical Officer Ram Chandani for not supervising the vaccination,' he said. Meanwhile, Shivansh's father has lodged a First Information Report - in Barabanki against Yadav and the nurse in connection with his son's death. http://www.rxpgnews.com    |
| Agilent Technologies and A*STAR launch all-in-one drug screening platform Posted: 21 Jul 2011 05:00 AM PDT ( From http://www.rxpgnews.com ) Agilent Technologies Inc. (NYSE: A) and A*STAR's Experimental Therapeutics Centre (ETC) today announced the launch of a drug screening platform within ETC's new Singapore Screening Centre. This partnership will provide a full spectrum of state-of-the-art automation technologies to biomedical researchers, enabling highly efficient drug screening in one location. The Singapore Screening Centre conducts high-throughput screening to identify potential drug candidates against disease, using a library of over 300,000 chemical compounds. It now employs Agilent's dual BioCel 1200 integrated system, which automates and coordinates the various processes of high-throughput screening, including compound management, assay plate preparation and experiment replication, to ensure high-quality data while saving time and reducing the possibility of human error. The location of Agilent's technology platform within ETC's newly set up Singapore Screening Centre will not only enhance our ability to produce proprietary drugs for Singapore, but also enable us to engage a diversity of biomedical research players from across the world, said Dr. Alex Matter, CEO of ETC. We expect collaborations with top private sector partners such as Agilent will go a long way to accelerate the development of medical solutions. The centerpiece of Agilent's BioCel System is a Direct Drive Robot (DDR) that provides significant advantages in speed and ease of use with its one-touch teaching and innovative design. The BioCel system is also customised specifically to ETC's requirements, linking the instruments to ETC's laboratory information management system so that the BioCel database and sample inventory are synchronised and up to date. The new platform will boost ongoing drug discovery projects at the Singapore Screening Center, including a collaboration with Duke University and the National University of Singapore Graduate Medical School to screen for novel gastric... http://www.rxpgnews.com   |
| Posted: 21 Jul 2011 05:00 AM PDT ( From http://www.rxpgnews.com ) An invasive insect, hemlock woolly adelgid, has been marching north along the Appalachians, killing almost every hemlock tree in its path. The adelgid has devastated forests in Georgia, Tennessee, and Virginia. The pest recently arrived in Vermont and other parts of New England. So far, only extreme cold stops the adelgid. But now a University of Vermont scientist has developed what he calls a fungal microfactory technology that promises to give forest managers and homeowners a tool to fight back. Working with the U.S. Forest Service, the State of Vermont, and others, Scott Costa, a UVM entomologist, has combined sweet whey, a byproduct of cheesemaking, with an insect-killing fungus to create an EPA-registered bio-pesticide that, in trials, was able to reduce the pest's growth rate. In Vermont trees with a high level of infestation, the treatment brought down the population of the adelgid, while in adjacent control trees, that were not treated, the pest population tripled. This mixture, that Costa calls Mycomax, seems likely to provide cost-effective protection for hemlock trees in native forests as well as landscaping contexts. In 2009, Costa had success with field trials on one-acre forest plots in Tennessee, using helicopters to drop the fungus mixture into the epicenter of the adelgid's devastating attack. Though no scientists think the pest can be wholly eliminated, these trials reduced the growth rate of adelgid by fifty percent. That's the first time that's been demonstrated with an insect-killing fungus, Costa says. And slowing the pest's growth seems likely to give trees a fighting chance of recovery. Over the last year, Costa has been testing the same technology on single trees in Townshend State Park in Vermont to see if ground-based spray applications will work, too. On June 7, 2011, he released a report to the State of Vermont that presents data showing that, treatment by the fungus suppressed HWA population... http://www.rxpgnews.com   |
| BUSM/BMC researchers awarded $3.5 million grant from the NIDA Posted: 21 Jul 2011 05:00 AM PDT ( From http://www.rxpgnews.com ) (Boston) - Researchers from the Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) were recently awarded a $3.5 million grant from the National Institute on Drug Abuse (NIDA), to improve upon the seek, test, treat, and retain paradigm in Eastern Europe among HIV-infected Russian and Eastern European injection drug users (IDUs) in narcology (addiction) care. The project will be known as LINC, Linking Infectious and Narcology Care. Russia and Eastern Europe have one of the fastest growing HIV epidemics in the world, with transmission risk primarily from injection drug use. Russia, Ukraine and other countries in the region have implemented routine HIV testing within established addiction treatment systems (narcology hospitals). The narcology system of care, however, works largely independent of other medical care systems and hence has not adopted strategies to link HIV-infected patients to HIV care. The research will be conducted under the direction of Jeffrey H. Samet, MD, a professor of medicine and community health sciences at BUSM and BU School of Public Health and chief of the Section of General Internal Medicine at BMC. Samet was recently selected as a NIDA International Program 2011 Awards of Excellence winner. According to the researchers, the narcology system of care works largely independent of other medical care systems and hence has not adopted strategies to link HIV-infected patients to HIV care. As in the United States in the 1990s, delayed or non-receipt of HIV medical care, particularly among IDUs, is common in Russia. According to Samet, the principal investigator of the study, this is a missed opportunity since up to 45 percent of Russian IDUs in narcology treatment are HIV infected, yet as few as 20 percent of those infected are in care. The objective of this study is to implement and assess a behavioral and structural intervention in Russia designed to support and motivate HIV-infected... http://www.rxpgnews.com   |
| Social media study: Conservatives were top tweeters in 2010 elections Posted: 21 Jul 2011 05:00 AM PDT ( From http://www.rxpgnews.com ) ANN ARBOR, Mich.---The results of a study on candidates' use of Twitter in the 2010 midterm elections suggest that Republicans and Tea Party members used the social medium more effectively than their Democratic rivals. The University of Michigan study, among the first to examine the Tea Party's social media strategies, also showed that analyzing Twitter activity can lead to good predictions of election winners. Various social media tools have become a key part of campaign strategies in recent years. In 2010, nearly a quarter of online adults used social networks including Twitter to engage with the election. In this study, researchers from the U-M School of Information and the College of Engineering looked at more than 460,000 tweets---three years' worth from 687 candidates running for national House, Senate and gubernatorial seats. The conservative candidates---Republicans and Tea Party members---definitely used Twitter more visibly and showed a more coherent set of messages and topics, said Eytan Adar, assistant professor in the School of Information and the Department of Electrical Engineering and Computer Science. They also followed each other much more closely. I think it's fair to say they were much more cohesive in a lot of ways and at the end of the day that makes for a stronger campaign. Conservatives, who made major gains in the 2010 midterm elections, tweeted about similar topics and conveyed a coherent message with a particular attention to economic issues, the researchers found. The top terms in Republicans' posts were spending, bills, budget, WSJ (Wall Street Journal), Bush and deficit. Over the study period, Republicans tweeted an average of 723 times. With an average of 551 tweets (text entries) during the study period, Democrats posted less frequently. Their tweets covered a wider range of topics. Top terms were education, jobs, oil_spill, clean_energy, Afghanistan, and reform. The study zeroed in on the... http://www.rxpgnews.com   |
| You are subscribed to email updates from RxPG News : Latest Medical, Healthcare and Research News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
Post a Comment